Immunogenicity of Biosimilar Therapeutics in Drug Development (Q167968)

From geokb
Revision as of 21:11, 12 September 2024 by Sky (talk | contribs) (‎Changed label, description and/or aliases in en, and other parts: removed aliases from OpenAlex keywords)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Investigating the safety and effectiveness of biosimilar drugs, including testing methods and potential side effects.
Language Label Description Also known as
English
Immunogenicity of Biosimilar Therapeutics in Drug Development
Investigating the safety and effectiveness of biosimilar drugs, including testing methods and potential side effects.

    Statements

    0 references
    0 references